Patient Information Sheets

These documents are for your information and are specifically for patients attending The Centre for Digestive Diseases.

Patient Information Booklet

Information about your Procedure and Risks

Patient Preparation Instructions

Australian Charter of Healthcare Rights

If you cannot view the above documents please click on the link below to download Acrobat Reader.

Patient Information
Get Adobe Acrobat Reader Trust Mark

Resistant Helicobacter pylori

How do we eradicate it?

Standard first-line treatment for H. pylori infection is marketed throughout Australia. Unfortunately, once a patient has been treated using a standard first-line treatment, but fails to eradicate the infection, the H. pylori remaining can become resistant to a number of the antibiotics used. As such it is imperative that the patient is treated with different antibiotics to reduce the likelihood of creating a "super-resistant" infection.

At the Centre for Digestive Diseases we have developed a second-line treatment which we have seen a success rate of greater that 96% (published data), compared to re-treating with the same or similar first-line treatments which have a low success rate.

Our second-line treatments, which are adjusted to suit each patient based on the number and type of previous treatment, can include the following medications: Rifabutin, Bismuth subsalicylate Furazolidone, Lactoferrin, Nitazoxanide and Levofloxacin.